Short Message System (SMS) Monitoring Intended for the Suicidal Patients
This study is completed. It focuses on suicide prevention and currently lists study information in France.
SuicidalityDeviceOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Efficiency may be useful for adults experiencing suicide prevention.
What would participation involve?
Participants may receive Efficiency, attend study visits with the research team. The registry lists locations in France.
Who is it mainly for?
This study appears to be mainly for adults with suicide prevention.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
France · 13 sites
CHU Angers
Angers
Site status: Not listed — confirm with the team
CHRU de Brest
Brest
Site status: Not listed — confirm with the team
CHU Caen
Caen
Site status: Not listed — confirm with the team
CHRU Lille
Lille
Site status: Not listed — confirm with the team
CHU de Lyon
Lyon
Site status: Not listed — confirm with the team
CHU Nantes
Nantes
Site status: Not listed — confirm with the team
CH Quimperlé
Quimperlé
Site status: Not listed — confirm with the team
CHU Rennes
Rennes
Site status: Not listed — confirm with the team
CHU de Saint-Etienne, Hôpital Nord
Saint-Etienne
Site status: Not listed — confirm with the team
CHU St Nazaire
Saint-Nazaire
Site status: Not listed — confirm with the team
CH St Malo
St-Malo
Site status: Not listed — confirm with the team
CHU Tours
Tours
Site status: Not listed — confirm with the team
CH Vannes
Vannes
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medical device for people with suicide prevention. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a device, app, or technology?
This appears to be a device / app / digital / technology study involving SMS contact with patient after discharge in intervention group. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with suicide prevention; age range: Over 18 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What should I check about data, monitoring, alerts, and daily use?
If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by University Hospital, Brest, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.